Skip to main content
OpenTrials
Completed

NCT Number: NCT06102122

Acceptability and Tolerance Study of Adult Tube Feed with Food with Food Derived Ingredients.

Product acceptability data from 15 participants are required in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) and the Health Service Executive (HSE) submission for Ireland for product registration.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

16 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tanita Flood

London, United Kingdom

About this study

To evaluate the acceptability (including gastrointestinal tolerance and compliance) of an adult tube-feed formula with ingredients derived from food for the dietary management of participants who require a tube feed. .

The acceptability data from 15 participants will be collected in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) and the Health Service

Executive (HSE) for Ireland. Participants will be provided with one month supply of tube feed and will be asked to complete a daily diary and short questionnaire to record information allowing assessment of the following:

  • Gastrointestinal tolerance
  • Compliance with prescribed feed volumes

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Require a tube feed (taking >75% of energy needs from their feeding tube) as part of their dietary management for disease related malnutrition
  • Adults and children requiring an adult enteral formula as assessed by the dietitian.
  • Patients well-established and stable on a standard formula or currently on Isosource® Junior Mix.
  • Willingly given, written, informed consent from patient or consultee. For those who lack capacity to provide formal consent for themselves, this may be provided by a personal or consultee in accordance with the Mental Capacity Act.
  • Willingly given, written assent (if appropriate) on behalf of patients under 18.

Exclusion criteria

  • Inability to comply with the study protocol, in the opinion of the investigator
  • Known food allergies to any ingredients (see ingredients list)
  • Patients with significant renal or hepatic impairment - Change in current medication or use of additional macro/micronutrient supplements during the study period, unless clinically indicated and prescribed by the investigator (must be recorded in patient case record file).
  • Participation in another interventional study within 2 weeks of this study.

Treatment and study plan

Compleat

Dietary Supplement

Patients well established and stable on a standard enteral tube feed with food derived ingredients will act as their own controls and make a product switch

Primary outcomes

  1. Daily record via participant diary

    Time frame: 7 days

    Daily Gastrointestinal diary as questionnaire, increase, decrease or no change

  2. Formula intake diary

    Time frame: 28 days

    mL per day

Sponsors and collaborators

Lead sponsor

Société des Produits Nestlé (SPN)

Industry

Registry information

Official study title

To Evaluate the Acceptability (including Gastrointestinal Tolerance and Compliance) of an Adult Tube-feed Formula with Ingredients Derived from Food.

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Oct 26, 2023
Registry last updated
Sep 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.